Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin a and verapamil on multidrug resistance in vitro and in vivo

Acta Oncologica

Volumn 34, Issue 2, 1995, Pages 235-241

  Watanabe, Toru ^a,c   Tsuge, Harumi ^b   Oh Hara, Tomoko ^a   Naito, Mikihiko ^b   Tsuruo, Takashi ^a,b  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Sandoz Pharmaceuticals Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DOXORUBICIN; VALSPODAR; VERAPAMIL; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; MULTIDRUG RESISTANCE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMAL; ANTINEOPLASTIC AGENTS; COMPARATIVE STUDY; CYCLOSPORINE; CYCLOSPORINS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; HUMAN; LEUKEMIA, MYELOID; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; TUMOR CELLS, CULTURED; VERAPAMIL; VINCRISTINE;

EID: 0028941366     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869509093961     Document Type: Article

References (30)

1. Mechanism of multidrug resistance and implications for therapy
2. Function and regulation of the human multidrug resistance gene
3. Pharmacology of drugs that alter multidrug resistance in cancer
4. Purification of the 170- to 180-kilodalton membrane glycoprotein associated with multidrug resistance: 170- to 180-kilodalton membrane glycoprotein is an ATPase
5. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil
6. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers
7. Increased accumulation of vincristine and Adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors
8. Potentiation of vincristine and Adriamycin in human hematopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors
9. Cyclosporin A reverses vincristine and daunomycin resistance in acute lymphatic leukemia in vitro
10. Cyclosporin A corrects dounomycin resistance in Ehrlich ascites carcinoma
11. Reversal of multidrug resistance by an immunosuppressive agent FK-506
12. In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52
13. In vivo evidence of complete circumventoin of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model
14. Reversal mechanism of multidrug resistance by verapamil, direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells
15. Identification of the multidrug resistance-related P-glycoprotein as a cyclosporine binding protein
16. A possible role for cyclosporins in cancer chemotherapy
17. In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC833
18. SDZ PSC 833, a non-immunosuppressive cyclosporin analog, is a very potent multidrug-resistance modifier
19. Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative
20. Pharmacologic interactions between the resistance-modifying cyclosporin SDZ PSC 833 and etoposide (VP 16–213) enhance in vivo cytostatic activity and toxicity
21. characteristics of vincristine resistance in vincristine resistant human myelogenous leukemia K562
22. Characteristics of resistance to Adriamycin in human myelogenous leukemia K562 resistant to Adriamycin and in isolated clones
23. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines
24. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells
25. Comparison of cyclosporin A and SDZ PSC 833 as multidrug resistance modulators in a daunorubicin-resistant Ehrlich ascites tumor
26. Reversal of typical multidrug resistance by cyclosporin and non-immunosuppressive analog SDZ PSC 833 in Chinese hamster ovary cells expressing the mdrl phenotype
27. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics
28. Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug
29. Overcoming of multidrug resistance by a new quinoline compound, MS-209
30. Kinetic analysis of hepatobiliary transport of vincristine in perfused rat liver: Possible roles of P-glycoprotein in biliary excretion of vincristine